Clinical Trial Update: Markers of Defective Membrane Remodelling in Scott-like Syndromes

View source ↗

Summary

A clinical trial investigating markers of defective membrane remodelling in Scott-like syndromes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scott Syndrome

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Unexplained Isolated Provoked Hemorrhages, Familial Bleeding Disorder | Status: TERMINATED